Having trouble accessing articles? Reset your cache.

BTT-1023: Phase I data

Top-line data from a double-blind, placebo-controlled, multiple ascending-dose, European Phase I trial in 26 patients showed that up to 8 mg/kg

Read the full 212 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE